Oncology & Cancer

New findings on prostate cancer screening

The prostate-specific antigen test for prostate cancer was developed in the 1990s, quickly followed by an explosion of PSA screening for the disease and a further explosion of treatment. Treatment consists of either radiation ...

Oncology & Cancer

Research breakthrough sparks new hope for bowel cancer patients

Every year, over 15,500 Australians are diagnosed with bowel cancer, and it is the second leading cause of cancer deaths in the country. Over 1,700 (one in 10) of those diagnosed are young Australians aged under 50, and this ...

Oncology & Cancer

New bowel cancer drug target discovered

Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.

Oncology & Cancer

Accelerated biological aging may cause bowel cancer

Scientists have shown how accelerated biological aging measured by an epigenetic clock may increase the risk of bowel cancer, according to a report published today in eLife.

Oncology & Cancer

'Cancer-cooling' protein puts bowel cancer on ice

A protein in the immune system can be manipulated to help overcome bowel cancer, according to new research from The Australian National University (ANU). The research is published in Science Advances.

page 6 from 40